Kala Bio (KALA) Asset Utilization Ratio (2019 - 2022)
Kala Bio (KALA) posted Asset Utilization Ratio of 0.05 for Q4 2022, down 33.01% sequentially from 0.07 in Q3 2022, and down 33.11% YoY from 0.07 in Q4 2021.
Kala Bio (KALA) Asset Utilization Ratio (2019 - 2022) Analysis & Trends
Kala Bio has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.05 in Q4 2022.
- Quarterly Asset Utilization Ratio fell 33.11% year-over-year to 0.05 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.05 (down 33.11% YoY) and the FY2022 annual result came in at 0.03, down 44.75% from the prior year.
- Asset Utilization Ratio fell to 0.05 in Q4 2022 per KALA's latest filing, from 0.07 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.09 in Q2 2022 and troughed at 0.02 in Q2 2020.
- A 4-year average of 0.05 and a median of 0.05 in 2022 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio jumped 168.94% in 2021, then sank 33.11% in 2022.
- Over 4 years, Asset Utilization Ratio stood at 0.04 in 2019, then declined by 26.06% to 0.03 in 2020, then jumped by 136.83% to 0.07 in 2021, then tumbled by 33.11% to 0.05 in 2022.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.05, 0.07, and 0.09 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | Kala Bio | 9.87 Mn | 9.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.07 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | 0.07 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.04 |
| Dec 31, 2020 | 0.03 |
| Sep 30, 2020 | 0.02 |
| Jun 30, 2020 | 0.02 |
| Mar 31, 2020 | 0.03 |
| Dec 31, 2019 | 0.04 |